FDA Approves Durvalumab for Limited-Stage Small Cell Lung Cancer By Ogkologos - January 17, 2025 852 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ADRIATIC study Source RELATED ARTICLESMORE FROM AUTHOR Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Living Guideline EMA Recommends Extension of Indications for Datopotamab Deruxtecan MOST POPULAR EMA Recommends Extension of Indications for Darolutamide January 31, 2023 How Pelvic Floor Therapy Can Help People With Prostate Cancer and... December 13, 2022 Assisted Reproduction Treatments are Safe in Young Breast Cancer Survivors with... May 15, 2024 FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer June 27, 2025 Load more HOT NEWS Substantial Decrease in the Use of Minimally Invasive Surgery for Cervical... Tomorrow is National Prescription Drug Take-Back Day! Καρκίνος Δέρματος Deaths from Metastatic Melanoma Drop Substantially in the United States
